ATRIPLA- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated États-Unis - anglais - NLM (National Library of Medicine)

atripla- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated

a-s medication solutions - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - atripla® is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients 12 years of age and older. atripla is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to efavirenz, a component of atripla. coadminstration of atripla with voriconazole is contraindicated. efavirenz, a component of atripla, significantly decreases voriconazole plasma concentrations, and coadministration may decrease the therapeutic effectiveness of voriconazole. also, voriconazole significantly increases efavirenz plasma concentrations, which may increase the risk of efavirenz-associated side effects. because atripla is a fixed-dose combination product, the dose of efavirenz cannot be altered [see clinical pharmacology (12.3) tables 4 and 5]. pregnancy category d [see warnings and precautions (5.9)] antiret

Atripla Compresse rivestite con film Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

atripla compresse rivestite con film

gilead sciences switzerland sàrl - efavirenzum, emtricitabinum, tenofovirum disoproxilum - compresse rivestite con film - efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg per tenofoviri disoproxili fumaras, carmellosum natricum solo tenuti insieme, hydroxypropylcellulosum, magnesio stearas, cellulosum microcristallinum, natrii laurilsulfas, Überzug: macrogolum 3350, poli(alcole vinylicus), talco, e 171, e-172 (nero), e-172 (rosso), per compresso haze corrisp. sodio 11.22 mg. - le infezioni da hiv - synthetika

Atripla Comprimés pelliculés Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

atripla comprimés pelliculés

gilead sciences switzerland sàrl - efavirenzum, emtricitabinum, tenofovirum disoproxilum - comprimés pelliculés - efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg de tenofoviri disoproxili fumaras, carmellosum natricum seulement tenus ensemble, hydroxypropylcellulosum, magnésium stearas, cellulosum microcristallinum, natrii laurilsulfas, Überzug: macrogolum 3350, le poly(alcool vinylicus), talc, e 171, e-172 (noir), e-172 (rouge), pour compresso haze corresp. sodium 11.22 mg. - les infections à vih - synthetika

ATRIPLA Australie - anglais - Department of Health (Therapeutic Goods Administration)

atripla

gilead sciences pty ltd - emtricitabine; efavirenz; tenofovir disoproxil fumarate -

Atripla Filmtabletten Suisse - allemand - Swissmedic (Swiss Agency for Therapeutic Products)

atripla filmtabletten

gilead sciences switzerland sàrl - efavirenzum, emtricitabinum, tenofovirum disoproxilum - filmtabletten - efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg bis tenofoviri disoproxili fumaras, carmellosum natricum nur zusammen gehalten, hydroxypropylcellulosum, magnesium stearas, cellulosum microcristallinum, natrii laurilsulfas, Überzug: macrogolum 3350, poly(alkohol vinylicus), talkum, e 171, e-172 (schwarz), e-172 (rot), für compresso haze endwerte. natrium 11.22 mg. - hiv-infektionen - synthetika

Atripla 600mg200mg245mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

atripla 600mg200mg245mg tablets

gilead sciences international ltd - efavirenz; tenofovir disoproxil fumarate; emtricitabine - tablet - 600mg ; 245mg ; 200mg

ATRIPLA TABLET Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

atripla tablet

msd (pty) ltd - tablet - see ingredients - each tablet contains efavirenz 600,0 mgemtricitabine 200,0 mgtenofovir disoproxil fumarate 300,0 mg

Triumeq Union européenne - espagnol - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infecciones por vih - antivirales para uso sistémico - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

ATRIPLA efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated États-Unis - anglais - NLM (National Library of Medicine)

atripla efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated

avera mckennan hospital - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg